New Microglia on the Block

Eun Sun Jung1, Inhee Mook-Jung1

  • 1Department of Biochemistry and Biomedical Sciences, Seoul National University, College of Medicine, Seoul 03080, South Korea; Neuroscience Research Institute, Seoul National University, College of Medicine, Seoul 03080, South Korea; SNU Dementia Research Center, Seoul National University, College of Medicine, Seoul 03080, South Korea.

Cell Metabolism
|April 9, 2020
PubMed

Insights

Newly identified lipid-droplet-accumulating microglia (LDAM) contribute to brain inflammation and neurodegeneration. This microglial state is linked to aging and disease, offering new therapeutic targets.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia, the brain's resident immune cells, display diverse functions and phenotypes.
  • These functions are influenced by factors such as age, health status, and disease context.
  • Understanding microglial heterogeneity is crucial for addressing neurological disorders.

Purpose of the Study:

  • To describe a newly identified microglial state.
  • To investigate the role of this state in neuronal inflammation and age-related neurodegeneration.
  • To establish lipid-droplet-accumulating microglia (LDAM) as a significant factor in brain pathology.

Main Methods:

  • Phenotypic characterization of microglia.
  • Analysis of lipid metabolism in microglia.
  • Investigation of microglial contribution to neuronal inflammation in vivo and in vitro.
  • Correlation of LDAM state with age-related neurodegenerative conditions.

Main Results:

  • Identification and characterization of a distinct microglial subpopulation: lipid-droplet-accumulating microglia (LDAM).
  • LDAM are associated with increased lipid accumulation.
  • LDAM state correlates with heightened neuronal inflammation.
  • The LDAM phenotype is implicated in age-related neurodegeneration.

Conclusions:

  • Lipid-droplet-accumulating microglia (LDAM) represent a critical cellular state involved in neuroinflammation.
  • LDAM contribute significantly to the pathogenesis of age-related neurodegeneration.
  • Targeting LDAM may offer a novel therapeutic strategy for neurodegenerative diseases.